Frank Mottola
SVP, Chief Tech. Ops. Officer · 5 filings · Latest: Mar 6, 2026
SUPERNUS PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | Mar 9, 2026 | Sale | $53.65 | 1,623 | $87.1K | 18,440 | |
SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | Mar 6, 2026 | Option Exercise | $0.00 | 3,750 | — | 21,856 | |
SUPN | FRANK MOTTOLA | — | Mar 9, 2026 | Proposed Sale | $53.65 | 1,623 | $87.1K | — | |
SUPN | FRANK MOTTOLA | — | Dec 19, 2025 | Proposed Sale | $49.28 | 20,000 | $985.6K | — | |
SUPN | FRANK MOTTOLA | — | Sep 12, 2025 | Proposed Sale | $45.87 | 5,000 | $229.3K | — | |
SUPN | FRANK MOTTOLA | — | Aug 25, 2025 | Proposed Sale | $44.51 | 14,000 | $623.1K | — | |
SUPN | FRANK MOTTOLA | — | Nov 7, 2024 | Proposed Sale | $36.98 | 15,000 | $554.7K | — |